Alan A. Musso

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Alan Musso
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Alan A. Musso:

Company Role Class Num Shares Value Price $ Report Date Ownership
Fulcrum Therapeutics, Inc. Chief Financial Officer Stock Option (right to buy) 170,000 02 Feb 2026 Direct
Rein Therapeutics, Inc. Director Stock Option (right to buy) 17,500 23 Jul 2025 Direct

Insider Reports Filed by Alan A. Musso

Symbol Company Period Transactions Value $ Form Type Role Filing Time
FULC Fulcrum Therapeutics, Inc. 02 Feb 2026 1 $0 4 Chief Financial Officer 04 Feb 2026, 16:10
RNTX Rein Therapeutics, Inc. 23 Jul 2025 1 $0 4 Director 23 Jul 2025, 19:38
FULC Fulcrum Therapeutics, Inc. 24 Jan 2025 1 $0 4 Chief Financial Officer 28 Jan 2025, 16:15
RNTX Aileron Therapeutics, Inc. 02 Dec 2024 1 $0 4 Director 06 Dec 2024, 16:32
RNTX Aileron Therapeutics, Inc. 20 Aug 2024 1 $0 4 Director 22 Aug 2024, 16:05
FULC Fulcrum Therapeutics, Inc. 26 Jan 2024 1 $0 4 Chief Financial Officer 30 Jan 2024, 21:05
FULC Fulcrum Therapeutics, Inc. 17 Jan 2024 1 $0 4 Chief Financial Officer 19 Jan 2024, 16:15
RNTX AILERON THERAPEUTICS INC 31 Oct 2023 1 $0 4 Director 02 Nov 2023, 20:53
RNTX AILERON THERAPEUTICS INC 31 Oct 2023 0 $0 3 Director 02 Nov 2023, 20:51
FULC Fulcrum Therapeutics, Inc. 07 Aug 2023 1 $0 4 Chief Financial Officer 09 Aug 2023, 16:16
FULC Fulcrum Therapeutics, Inc. 07 Aug 2023 0 $0 3 Chief Financial Officer 09 Aug 2023, 16:11